{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:02:23Z","timestamp":1792544543500,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ijwd.2020.02.007","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T17:06:37Z","timestamp":1582650397000},"page":"159-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa"],"prefix":"10.1097","volume":"6","author":[{"given":"Kevin T.","family":"Savage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Gonzalez","family":"Brant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rosales Santillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9200-9939","authenticated-orcid":false,"given":"Peyton C.","family":"Morss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Salian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey S.","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina L.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa B.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1","key":"10.1016\/j.ijwd.2020.02.007_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/nu11010057","article-title":"Role of nutrition and adherence to the Mediterranean diet in the multidisciplinary approach of hidradenitis suppurativa: Evaluation of nutritional status and its association with severity of disease","volume":"11","author":"Barrea","year":"2019","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.ijwd.2020.02.007_b0010","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1073\/pnas.88.6.2441","article-title":"Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells","volume":"88","author":"Cronstein","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijwd.2020.02.007_b0015","article-title":"Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections","volume":"6","author":"Crowley","year":"2018","journal-title":"SAGE Open Med Case Rep"},{"issue":"2","key":"10.1016\/j.ijwd.2020.02.007_b0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000431037","article-title":"Hidradenitis suppurativa management in the United States: an analysis of the National Ambulatory Medical Care Survey and MarketScan Medicaid Databases","volume":"1","author":"Davis","year":"2015","journal-title":"Skin Appendage Disord"},{"issue":"2","key":"10.1016\/j.ijwd.2020.02.007_b0025","first-page":"185","article-title":"SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate","volume":"69","author":"De Souza","year":"2011","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.ijwd.2020.02.007_b0030","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"103208","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"10.1016\/j.ijwd.2020.02.007_b0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"17","key":"10.1016\/j.ijwd.2020.02.007_b0040","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2217\/pgs-2019-0121","article-title":"Methotrexate pharmacogenetics in the treatment of rheumatoid arthritis","volume":"20","author":"Jekic","year":"2019","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.ijwd.2020.02.007_b0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2230.2002.11125.x","article-title":"Methotrexate is of limited value in the treatment of hidradenitis suppurativa","volume":"27","author":"Jemec","year":"2002","journal-title":"Clin Exp Dermatol"},{"issue":"18","key":"10.1016\/j.ijwd.2020.02.007_b0050","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1056\/NEJM198311033091805","article-title":"The pharmacology and clinical use of methotrexate","volume":"309","author":"Jolivet","year":"1983","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ijwd.2020.02.007_b0055","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjd.14214","article-title":"Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa","volume":"174","author":"Lima","year":"2016","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.ijwd.2020.02.007_b0060","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/17512433.2018.1509706","article-title":"Unconventional therapies for hidradenitis suppurativa","volume":"11","author":"Marasca","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.ijwd.2020.02.007_b0065","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jdcr.2018.12.002","article-title":"Secukinumab and hidradenitis suppurativa: friends or foes?","volume":"5","author":"Marasca","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.ijwd.2020.02.007_b0070","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10067-018-4355-0","article-title":"The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors","volume":"38","author":"Martinez-Feito","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.ijwd.2020.02.007_b0075","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents","volume":"76","author":"Matusiak","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2020.02.007_b0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1159\/000446021","article-title":"Leukocyte profile in peripheral blood and neutrophil-lymphocyte ratio in hidradenitis suppurativa: a comparative cross-sectional study of 462 cases","volume":"232","author":"Miller","year":"2016","journal-title":"Dermatol Basel Switz"},{"issue":"1","key":"10.1016\/j.ijwd.2020.02.007_b0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00541349","article-title":"Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients","volume":"8","author":"O\u2019Callaghan","year":"1988","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.ijwd.2020.02.007_b0090","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjd.17822","article-title":"Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa","volume":"181","author":"Prussick","year":"2019","journal-title":"Br J Dermatol"},{"issue":"20","key":"10.1016\/j.ijwd.2020.02.007_b0095","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis suppurativa: advances in diagnosis and treatment","volume":"318","author":"Saunte","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ijwd.2020.02.007_b0100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0007-1226(03)00177-2","article-title":"Hidradenitis suppurativa: pathogenesis and management","volume":"56","author":"Slade","year":"2003","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.ijwd.2020.02.007_b0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000332846","article-title":"The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa","volume":"223","author":"van der Zee","year":"2011","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.ijwd.2020.02.007_b0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ijd.13740","article-title":"SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature","volume":"57","author":"Vekic","year":"2018","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2020.02.007_b0115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2133.1983.tb04598.x","article-title":"Methotrexate inhibits polymorphonuclear leucocyte chemotaxis in psoriasis","volume":"108","author":"Walsdorfer","year":"1983","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2020.02.007_b0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","article-title":"The natural history of hidradenitis suppurativa","volume":"14","author":"Werth","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.ijwd.2020.02.007_b0125","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/bjd.16560","article-title":"Methotrexate restores the function of peripheral blood regulatory T cells in psoriasis vulgaris via the CD73\/AMPK\/mTOR pathway","volume":"179","author":"Yan","year":"2018","journal-title":"Br J Dermatol"}],"updated-by":[{"DOI":"10.1016\/j.ijwd.2021.09.013","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000}}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647520300198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647520300198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T14:27:36Z","timestamp":1641565656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647520300198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2352647520300198"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2020.02.007","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijwd.2021.09.013","asserted-by":"object"}]},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2020.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}